Ad
related to: Novavax
Search results
Novavax (NVAX) Q2 Earnings Beat, Stock Down 4% on '23 Sales Cut
Zacks via Yahoo Finance· 8 months agoNovavax (NVAX) reports better-than-expected Q2 earnings results, as earnings and revenues beat...
EMA Panel Endorses Novavax's (NVAX) COVID Jab for Full Approval
Zacks via Yahoo Finance· 10 months agoNovavax's (NVAX) protein-based COVID-19 vaccine gets recommendation for full marketing authorization...
Novavax, Inc. (NASDAQ:NVAX) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 month agoNovavax, Inc. (NASDAQ:NVAX) Q4 2023 Earnings Call Transcript February 28, 2024 Novavax, Inc. misses...
Novavax (NVAX) Posts Upbeat Data on COVID/Flu Combo Jab Study
Zacks via Yahoo Finance· 2 years agoResults from Novavax's (NVAX) phase I/II study, which is evaluating a combination of its COVID-19...
Is Most-Watched Stock Novavax, Inc. (NVAX) Worth Betting on Now?
Zacks via Yahoo Finance· 2 years agoNovavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you...
Novavax Stock Is Alluringly Attractive at This Stage
InvestorPlace via Yahoo Finance· 2 years agoMore than 1,300 doses of Novavax’s (NVAX) Covid-19 vaccine have been given out in New Zealand in just two weeks The New Zealand government has bought...
Here's the Worst Mistake Novavax Investors Can Make in 2023
Motley Fool· 1 year agoNovavax (NASDAQ: NVAX) has taken investors on a wild ride since the start of the pandemic. The...
1 Reason to Buy Novavax in 2023 and 2 Reasons to Sell
Motley Fool· 1 year agoNovavax (NASDAQ: NVAX) has offered investors just such a ride over the past few years. Initial gains...
Novavax CEO eyes next batch of COVID-19 vaccines after CDC approval
Yahoo Finance via AOL· 2 years agoNovavax passed the finish line to gain authorization for its COVID-19 vaccine, and its first...
Is This a Good Sign for Novavax?
Motley Fool· 9 months agoNovavax (NASDAQ: NVAX) shares soared more than 30% in one trading session this week. The biotech stock has been in the doldrums ever since the company...